Literature DB >> 41435

Analysis of herpes simplex virus isolated from patients with recurrent herpes keratitis exhibiting "treatment-resistance" to 5-iodo-2'-deoxyuridine.

A Hirano, K Yumura, T Kurimura, T Katsumoto, H Moriyama, R Manabe.   

Abstract

Four strains of herpes simplex virus (HSV) were isolated from two patients with recurrent herpes keratitis who failed to respond to 5'-iodo-2'-deoxyuridine (IDU) treatment. Two of the four isolates were highly resistant to IDU in cell culture and the other two isolates were more susceptible to IDU than an HSV-1 laboratory strain. From each patient, an IDU-resistant and an IDU-susceptible virus was isolated. All 4 isolates possessed the ability to induce the thymidine kinase (TK) activity in cell lines lacking that activity. All the isolates were type 1 HSV, since the filamentous structures, recognized as a biological marker of type 2 HSV, were not observed in infected cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 41435

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  10 in total

1.  Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.

Authors:  R F Schinazi; J Peters; C C Williams; D Chance; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

2.  Oral acyclovir therapy of genital herpes simplex virus type 2 infections in guinea pigs.

Authors:  M N Ellis; D W Barry
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

Review 3.  Persistent herpes simplex virus infection and mechanisms of virus drug resistance.

Authors:  H J Field
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

4.  Antiherpesviral activity and inhibitory action on cell growth of 5-alkenyl derivatives of 1-beta D-arabinofuranosyluracil.

Authors:  H Machida; A Kuninaka; H Yoshino; K Ikeda; Y Mizuno
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

5.  Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.

Authors:  H J Field; G Darby
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

6.  Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants.

Authors:  R J Klein; A E Friedman-Kien; E DeStefano
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

7.  Differentiation of herpes simplex virus types 1 and 2 by sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.

Authors:  D R Mayo
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

8.  Alterations in substrate specificity and physicochemical properties of deoxythymidine kinase of a drug-resistant herpes simplex virus type 1 mutant.

Authors:  V Veerisetty; G A Gentry
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

9.  Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils.

Authors:  H Machida; S Sakata; A Kuninaka; H Yoshino
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

Review 10.  Rapid and accurate viral diagnosis.

Authors:  M L Landry; D R Mayo; G D Hsiung
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.